| Literature DB >> 34130713 |
Ioannis Doumas1,2,3, Gauthier Everard1,3, Stéphanie Dehem1,2,3, Thierry Lejeune4,5,6.
Abstract
BACKGROUND: Approximately two thirds of stroke survivors maintain upper limb (UL) impairments and few among them attain complete UL recovery 6 months after stroke. Technological progress and gamification of interventions aim for better outcomes and constitute opportunities in self- and tele-rehabilitation.Entities:
Keywords: Robotics; Serious games; Stroke; Upper extremity; Virtual reality
Year: 2021 PMID: 34130713 PMCID: PMC8204490 DOI: 10.1186/s12984-021-00889-1
Source DB: PubMed Journal: J Neuroeng Rehabil ISSN: 1743-0003 Impact factor: 4.262
List of neurorehabilitation principles with description established by Maier et al. [11, 16]
| Neurorehabilitation principle | Description | Fulfilled in studies (%) | ||
|---|---|---|---|---|
| All studies | + | = | ||
| Massed practice | Tasks aiming to increase the number of repetitions performed | 81 | 79 | 85 |
| Dosage | Intensive training: more than a daily session of 60 min on every weekday | 52 | 59 | 38 |
| Structured practice | Training that includes periods of rest | 26 | 31 | 15 |
| Task-specific practice | Functional training relevant to ADL | 100 | 100 | 100 |
| Variable practice | Training that includes different types of tasks | 98 | 97 | 100 |
| Multisensory stimulation | Training that provides more than two types of sensory feedback | 83 | 90 | 69 |
| Increasing difficulty | Complexity of tasks changes depending on participants’ ability, performance or time | 76 | 76 | 80 |
| Explicit feedback | Training that provides information about the patient’s performance at the end of the task | 79 | 93 | 46* |
| Implicit feedback | Training that delivers information about the performance in real time such as visualization of movement or other kinematic properties | 74 | 83 | 54 |
| Avatar representation | Embodied training by representation of a human or body part | 38 | 41 | 31 |
| Use of the paretic limb | Promoting the use of the paretic limb | 76 | 76 | 80 |
All studies, 42 included in meta-analysis
+ , studies with SMD in favour of the experimental group for main outcomes regarding upper limb function
= , studies with SMD in favour of the control group for main outcomes regarding upper limb function
*Statistically significant difference (p < 0.05) in Fischer’s exact test
Fig. 1Flow chart (PRISMA) of the selection process
Characteristics of included studies
| Author | Participantsa | Ageb | Stroke stage | Type of device | PEDro score |
|---|---|---|---|---|---|
| Adomaviciene [ | 42 | 64.6 | Subacute | Motion capture system, LCD monitor | 5 |
| Ang [ | 21 | 54.2 | Chronic | Haptic Knob robotic system, LCD monitor | 6 |
| Aprile [ | 224 | 69.5 | Subacute | 4 different robotic devices | 6 |
| Askin [ | 38 | 55.0 | Chronic | Motion capture system, LCD monitor | 6 |
| Brunner [ | 120 | 62.0 | Subacute | Motion capture gloves, LCD monitor | 7 |
| Cameirao [ | 19 | 61.0 | Subacute | Motion capture system, data gloves, LCD monitor | 5 |
| Cameirao [ | 44 | 62.0 | Chronic | Motion capture system, data gloves, LCD monitor | 6 |
| Cho [ | 38 | 60.0 | Chronic | End-effector robot, LCD monitor | 8 |
| Choi [ | 24 | 61.0 | Subacute | Smartphone and tablet computer | 6 |
| Crosbie [ | 18 | 60.0 | Chronic | Immersive VR motion tracking system | 8 |
| Dehem [ | 45 | 67.3 | Subacute | End-effector robot, LCD monitor | 7 |
| Duff [ | 21 | 68.5 | Chronic | Motion capture system, LCD monitor | 5 |
| Henrique [ | 31 | 76.0 | Chronic | Immersive VR motion tracking system | 5 |
| Housman [ | 28 | 55.0 | Chronic | Robotic exoskeleton, LCD monitor | 5 |
| Hung [ | 33 | 58.5 | Chronic | Motion capture system, LCD monitor | 7 |
| Jang [ | 10 | 57.1 | Chronic | Motion capture system, LCD monitor | 5 |
| Jo [ | 29 | 64.0 | Chronic | Motion capture system, LCD monitor | 5 |
| Kim [ | 23 | 53.5 | Subacute | Motion capture system, LCD monitor | 8 |
| Kiper [ | 80 | 64.0 | Subacute | Motion capture system, LCD monitor | 5 |
| Kiper [ | 44 | 64.3 | Subacute | Motion capture system, LCD monitor | 5 |
| Kiper [ | 136 | 63.9 | Subacute | Motion capture system, LCD monitor | 6 |
| Klamroth-Marganska [ | 73 | 56.5 | Chronic | Robotic exoskeleton, LCD monitor | 8 |
| Kottink [ | 18 | 61.5 | Chronic | Motion capture system, LCD monitor | 6 |
| Kwon [ | 26 | 57.5 | Subacute | Motion capture system, LCD monitor | 5 |
| Laffont [ | 51 | 58.0 | Subacute | Touchscreen interface, computer monitor | 8 |
| Lee [ | 26 | 67.5 | Chronic | Motion capture system, LCD monitor | 8 |
| Lee [ | 18 | 71.1 | Chronic | Motion capture system, LCD monitor | 6 |
| Lee [ | 30 | 51.0 | Chronic | End-effector robot, LCD monitor | 6 |
| Levin [ | 12 | 58.5 | Chronic | Motion capture system, LCD monitor | 6 |
| Liao [ | 20 | 54.5 | Chronic | End-effector robot, LCD monitor | 7 |
| Mugler [ | 32 | 58.0 | Chronic | Surface EMG-controlled sensor, computer monitor | 6 |
| Nijenhuis [ | 19 | 60.0 | Chronic | Arm support system | 6 |
| Norouzi-Gheidari [ | 18 | 49.9 | Chronic | Motion capture system, LCD monitor | 7 |
| Ogun [ | 65 | 60.6 | Chronic | Immersive VR motion tracking system | 6 |
| Oh [ | 31 | 55.0 | Chronic | 3-D manipulator, computer monitor | 7 |
| Park [ | 25 | 52.5 | Chronic | 2-D planar motion handlebar, LCD monitor | 7 |
| Piron [ | 36 | 65.2 | Chronic | Motion capture camera, computer monitor | 7 |
| Piron [ | 47 | 60.5 | Chronic | Motion capture system, LCD monitor | 8 |
| Prange [ | 68 | 59.1 | Subacute | Arm support system, computer monitor | 7 |
| Rogers [ | 21 | 64.4 | Subacute | Touchscreen mega-tablet | 6 |
| Schuster-Amft [ | 54 | 61.3 | Chronic | Motion capture gloves, LCD monitor | 8 |
| Shin [ | 16 | 49.3 | Subacute | Motion capture system, LCD monitor | 5 |
| Shin [ | 32 | 54.0 | Chronic | Motion capture system, LCD monitor | 6 |
| Shin [ | 46 | 58.5 | Chronic | Motion capture gloves, LCD monitor | 7 |
| Subramanian [ | 32 | 61.0 | Chronic | Motion capture system, LCD monitor | 7 |
| Thielbar [ | 14 | 56.5 | Chronic | Pneumatically actuated motion capture gloves | 6 |
| Thielbar [ | 20 | 59.7 | Chronic | Motion capture system, LCD monitor | 5 |
| Tomic [ | 26 | 57.4 | Subacute | End-effector robot, LCD monitor | 7 |
| Wolf [ | 99 | 56.9 | Chronic | End-effector robot, computer touch screen | 7 |
| Yin [ | 23 | 58.3 | Subacute | Motion capture system, computer monitor | 6 |
| Zondervan [ | 17 | 59.5 | Chronic | Motion capture gloves, computer monitor | 6 |
LCD monitor, liquid–crystal display monitor; 3-D, 3-Dimensional; 2-D, 2-Dimensional
aParticipants: number of total participants in study
bAge: mean age in years estimated for total number of participants included in each study
Duration, matched groups, outcome measurements, overall findings, number of included neurorehabilitation principles
| Authors and publication year | Durationa | Matched groupsb | UL function | UL activity | Participation | Overall findingsc | Principlesd |
|---|---|---|---|---|---|---|---|
| Adomaviciene, 2019 [ | 2 | ✓ | FMA-UE | BBT | + | 4 | |
| Ang, 2014 [ | 6 | ✓ | FMA-UE | = | 5 | ||
| Aprile [ | 6 | ✓ | FMA-UEs | ARATs | = | 10 | |
| Askin, 2018 [ | 4 | X | FMA-UEm, s | BBTm, s | + | 6 | |
| Brunner, 2017 [ | 4 | ✓ | ARATs, BBT | = | 4 | ||
| Cameirao, 2011 [ | 12 | ✓ | FMA-UE | + | 6 | ||
| Cameirao, 2012 [ | 4 | ✓ | FMA-UE | BBT | + | 6 | |
| Cho, 2019 [ | 6 | ✓ | FMA-UE | ARAT, BBT | + | 6 | |
| Choi, 2016 [ | 2 | ✓ | FMA-UE s | + | 8 | ||
| Crosbie, 2012 [ | 3 | ✓ | ARAT s | = | 6 | ||
| Dehem, 2019 [ | 9 | ✓ | FMA-UE | BBT | SIS | + | 9 |
| Duff, 2013 [ | 4 | ✓ | FMA-UEm, s | WMFTm, s | SIS | = | 9 |
| Henrique, 2019 [ | 12 | ✓ | FMA-UE | + | 9 | ||
| Housman, 2009 [ | 9 | ✓ | FMA-UE | + | 5 | ||
| Hung, 2019 [ | 12 | ✓ | FMA-UEm, s | WMFTm, s | = | 8 | |
| Jang, 2005 [ | 4 | ✓ | FMAs | BBTs | + | 10 | |
| Jo, 2012 [ | 4 | X | WMFT | + | 9 | ||
| Kim, 2018 [ | 2 | ✓ | FMA-UEs | BBTs | = | 7 | |
| Kiper, 2011 [ | 4 | ✓ | FMA-UEs | + | 9 | ||
| Kiper, 2014 [ | 4 | ✓ | FMA-UEs | + | 9 | ||
| Kiper, 2018 [ | 4 | ✓ | FMA-UEs | + | 8 | ||
| Klamroth-Marganska, 2014 [ | 8 | ✓ | FMA-UE | SIS | + | 7 | |
| Kottink, 2014 [ | 6 | ✓ | FMA-UE | ARAT | = | 6 | |
| Kwon, 2012 [ | 4 | X | FMA-UEs | = | 5 | ||
| Laffont [ | 6 | ✓ | FMA-UE | BBT, WMFT | = | 8 | |
| Lee, 2016a [ | 8 | ✓ | FMA-UEs | BBTs | + | 8 | |
| Lee, 2016b [ | 6 | ✓ | BBT | + | 9 | ||
| Lee, 2018 [ | 8 | ✓ | FMA-UEs | + | 8 | ||
| Levin, 2012 [ | 3 | ✓ | FMA-UEs | BBTs, WMFT | + | 9 | |
| Liao, 2012 [ | 4 | ✓ | FMA-UEs | + | 7 | ||
| Mugler, 2019 [ | 3 | X | FMA-UE | = | 8 | ||
| Nijenhuis, 2017 [ | 6 | ✓ | FMA-UEm, s | ARATm, s, BBT | SIS | = | 5 |
| Norouzi-Gheidari, 2019 [ | 4 | X | FMA-UEs | BBTs | SISs | + | 8 |
| Ogun, 2019 [ | 6 | ✓ | FMA-UEs | ARATs | + | 8 | |
| Oh, 2019 [ | 6 | ✓ | FMA-UE | BBT | + | 9 | |
| Park, 2019 [ | 4 | ✓ | FMA-UE | WMFT | SIS | = | 9 |
| Piron, 2009 [ | 4 | ✓ | FMA-UEs | + | 8 | ||
| Piron (2010) [ | 4 | ✓ | FMA-UEs | + | 10 | ||
| Prange, 2015, [ | 6 | ✓ | BBT | + | 9 | ||
| Rogers2019 [ | 4 | X | FMA-UEs | = | 5 | ||
| Schuster-Amft, 2018 [ | 4 | ✓ | BBTm, s | SIS | = | 7 | |
| Shin, 2014 [ | 2 | X | FMA-UEs | = | 8 | ||
| Shin, 2015 [ | 4 | ✓ | FMA-UEm, s | = | 9 | ||
| Shin, 2016 [ | 4 | ✓ | FMA-UEs | SISs | + | 10 | |
| Subramanian, 2012 [ | 4 | ✓ | FMA-UE | + | 8 | ||
| Thielbar, 2014 [ | 6 | ✓ | FMA-UEs | ARATs | + | 10 | |
| Thielbar, 2020 [ | 4 | ✓ | FMA-UE | + | 8 | ||
| Tomic, 2017 [ | 3 | ✓ | FMA-UE | WMFT | + | 8 | |
| Wolf, 2015 [ | 8 | ✓ | FMA-UEs | ARATs, WMFT | = | 6 | |
| Yin, 2014 [ | 2 | ✓ | FMA-UEm, s | ARATm, s | = | 11 | |
| Zondervan, 2016 [ | 3 | ✓ | ARAT, BBT | = | 7 |
UL upper limb, FMA-UE Fugl-Meyer Assessment Upper Extremity subscale, ARAT action research arm test, BBT box and block test, WMFT Wolf-motor function test, SIS stroke impact scale, ✓, matched time between interventions; X, time between interventions not matched; + , statistically significant improvement in favour of experimental group for main outcomes; = , no statistically significant differences reported between experimental and control group
aDuration: total number of treatment weeks
bMatched groups: matched time in terms of daily session time, sessions per week and total number of weeks between experimental and control group
cOverall findings: reported findings concerning primary outcome measures
dPrinciples: total number of neuro-rehabilitation principles fulfilled by the serious game used in the intervention. A total of 11 principles were examined for each trial
mStudies that reported only median and quartiles
sStudies for which the standard deviation had to be estimated
Fig. 2Forest plot of upper limb motor function as measured by the FMA-UE: studies using a serious game fulfilling ≥ 8 Npr versus studies using a serious game fulfilling < 8 Npr. FMA-UE upper extremity subscale of the Fugl-Meyer Assessment, Npr neurorehabilitation principles
Fig. 3Forest plot of upper limb motor function as measured by the FMA-UE: studies in the subacute phase after stroke versus studies in the chronic phase after stroke. FMA-UE, upper extremity subscale of the Fugl-Meyer Assessment
Fig. 4Forest plot of upper limb activity as measured by the ARAT, BBT, WMFT: studies using a serious game fulfilling ≥ 8 Npr versus studies using a serious game fulfilling < 8 Npr. ARAT action research arm test, BBT box and block test, WMFT Wolf motor function test, Npr neurorehabilitation principles
Fig. 5Forest plot of participation as measured by the social participation subscale of the SIS. SIS stroke impact scale